Literature DB >> 4346865

Results of a clinical trial with intermittent doses of adriamycin in lung cancer.

Y Kenis, J Michel, R Rimoldi, P Lévy, L Israël.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4346865     DOI： 10.1016/0014-2964(72)90098-9

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  3 in total

1.  Sensitivity tests of tumors to cytostatic agents. II. Investigation on human tumors.

Authors:  J Mattern; M Kaufmann; H Hinderer; K Wayss; M Volm
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1975

2.  Differences in doxorubicin-induced apoptotic signaling in adult and immature cardiomyocytes.

Authors:  Eugene A Konorev; Sravan Vanamala; Balaraman Kalyanaraman
Journal:  Free Radic Biol Med       Date:  2008-09-20       Impact factor: 7.376

3.  High Throughput Screening Identifies a Novel Compound Protecting Cardiomyocytes from Doxorubicin-Induced Damage.

Authors:  Szabolcs Gergely; Csaba Hegedűs; Petra Lakatos; Katalin Kovács; Renáta Gáspár; Tamás Csont; László Virág
Journal:  Oxid Med Cell Longev       Date:  2015-06-07       Impact factor: 6.543
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.